ASCPT Podcast Channel
MENU  

Tagged: CTS

Call for Papers: Real-World Evidence and Real-World Data

Join Editor-in-Chief Dr. John Wagner and Associate Editor Dr. Paulien Ravenstijn as they discuss the FIRST EVER Call for Papers from Clinical and Translational Science (CTS). This special collection focusing on Real-World Evidence and Real-World Data, which will be a rolling collection, will initially publish in the second half of 2023, and the CTS editorial team will be considering submissions for the issue through early September of 2023. This Call was developed around the ASCPT 2023 Annual Meeting Pre-Conference “Advancing the Utilization of Real-World Data (RWD) and Real-World Evidence (RWE) in Clinical Pharmacology and Translational Research,” so if you have questions about the suitability of the topic for inclusion in the issue, please feel free to contact Paulien or pre-conference co-Chairs Dr. Karen Rowland Yeo and Dr. Jing Liu.

ASCPTPod
ASCPTPod
Call for Papers: Real-World Evidence and Real-World Data
Loading
/

Peer Review: After the Review

In the fourth episode in the peer review series, Dr. Stefanie Hennig joins host Alaina Webster to walk you through what editors do with a review once it’s received. Stefanie, an Associate Editor for CPT: Pharmacometrics & Systems Pharmacology details her first steps upon receiving a review, how much a reviewer’s opinion influences her decision on a manuscript, and how she decides is reviewers are needed for a revised manuscript.

You can access PSP’s Reviewer Instructions and contact the editorial office to volunteer as a reviewer here.

PSPod
PSPod
Peer Review: After the Review
Loading
/

Peer Review: What’s Not Helpful in a Review?

ClinPharmPod’s peer review series continues as host Alaina Webster is chats with Dr. Richard Peck about what to avoid when completing a review. They cover what’s too little and what’s too much in a review, the appropriate tone to strike when providing feedback, and the tricky topic that is unconscious bias.

You can access CPT’s Reviewer Instructions and contact the editorial office to volunteer as a reviewer here.

ClinPharmPod
ClinPharmPod
Peer Review: What’s Not Helpful in a Review?
Loading
/

Pharmacogenetics and Underrepresented Populations

Dr. Erica Woodahl is back as moderator to discuss “Applying an equity lens to pharmacogenetic research and translation to underrepresented populations” with Clinical and Translational Science authors Drs. Tiana Luczak and Jacob Brown. They break down the challenges to conducting pharmacogenetic studies in underrepresented populations, what steps researchers can take to overcome these obstacles, and why equitable studies for underrepresented groups is vital to the future of clinical pharmacology and translational science.

You can access Tiana and Jacob’s fully Open Access paper here.

ClinPharmPod
ClinPharmPod
Pharmacogenetics and Underrepresented Populations
Loading
/

Peer Review: What’s Most Important in a Review?

In the second installment of ClinPharmPod’s six-part peer review series, host Alaina Webster is joined by returning guest Dr. Deanna Kroetz, Professor at the University of California, San Francisco in the Department of Bioengineering Therapeutic Sciences and Deputy Editor-in-Chief of Clinical and Translational Science (CTS). They break down the top three things Deanna looks for when undertaking a peer review as well as the importance of peer review to sound science.

You can access CTS’s Reviewer Instructions here.

ClinPharmPod
ClinPharmPod
Peer Review: What’s Most Important in a Review?
Loading
/
Copyright © 2020-2025 John Wiley & Sons, Inc. All Rights Reserved.